Tribal Sports Nutrition (TSN) uses the revitalising properties of the Baobab fruit to create energy smoothies. TSN claims that its smoothies are less concentrated than other sports nutrition brands, are 100% organic, and easy on the stomach. The company also incorporates vitamin C, antioxidants, fibre, and electrolytes into the smoothies to make it the on-the-go snack for active lifestyle consumers. TSN asserts that its baobab ingredient is wild-harvested by cooperatives in Africa, bringing income to people and preserving the local ecology. The company received a certification from the Organic Food Federation (OFF) and aims to achieve B Corp status. TSN's products have been listed in Sainsbury's and on Amazon. It will use the investment to double its existing product offering in 2021 and launch hydration, plant protein recovery products, and Baobab energy snacks.
days to go:
Expired
investment:
£421,647
Artfinder is the art world's first certified B corporation that is on a mission to create a world where art benefits everyone. Operating in the $55 billion+ wall décor and online art market, the company is backed by Wellington Partners, and private investors in the UK, US and Switzerland. It has 60,000 customers, 6,000 artists and a collection of 470,000 artworks. The company believes in establishing direct contact with artists to select or commission work and negotiate prices. Customers have rated the company highly with 4.8+ Trustpilot reviews. The company will use the investment to supercharge its growth, grow its team and improve its platform.
days to go:
Expired
investment:
£834,056
miiCARE is a MedTech specialising in AI applied to geriatrics (elderly care). Its key product miiCUBE offers cutting-edge home-based and customised healthcare, helping the elderly enjoy their independence while being comprehensively connected to their families, friends, and neighbours. The company aims to provide these benefits to one billion people by 2028, comprising older people, family members and carers. Till date, miiCARE has secured partnerships with the UK’s largest NHS trust, Ebbsfleet Garden City, O2, Bristol Careline and Microsoft, and won multiple social impacts and digital health awards during the last 12 months. Funds raised will be used mainly for fulfilling pre-orders and close interests for large contracts with corporates, marketing and logistics, product development, sales and salaries.
days to go:
Expired
investment:
£103,672
Gendius is a company that aims to bring pharmaceuticals and health economics, through clinical research and evidence, to the mobile health market. Their latest innovation, Intellin, is an intelligent remote management diabetes platform, with over 140,000 downloads so far. The COVID-19 crisis has highlighted the need for remote home monitoring of patients, and the company feels that its product is a suitable contender in this domain. Intellin has a reliable connection to over 150 medical devices and apps, and also consists of a two-way communication setup with a healthcare professional via a secure dashboard. Gendius is registered as an approved vendor with AstraZeneca in Saudi Arabia and looks to establish deeper relations with the National Health Service (UK) to create a demand for its product. The company will use the investment to scale its business globally, drive commercialisation, offer an opportunity to its stakeholders, and target venture capital.
days to go:
Expired
investment:
£386,829
TV.FIT is a streaming service and app that allows its users to access 100 hours of health & wellbeing content from global fitness experts & celebrities. Its subscription service is accessible in 66 countries across 6 continents. The platform aims to cater to all aspects of fitness, from mental health support for those who have yet to start to improve their fitness to creating content for those who are already working on their fitness regime. Its programs are created by some of the world’s most well-known fitness figures including George St-Pierre, Caroline Pearce, Gemma Atkinson, and Pierre Pozzuto. The platform has a global multimedia reach of over 8 million followers via partners such as TruFusion and CoolEvents, with another 6 million+ prospective users in the pipeline. TV.FIT also disseminates NHS-recommended mental-health-focused content on its platform. With the funds received, the platform aims to invest 31% of it in marketing, 28% in international content development, 22% in capital reserves, 18% in content production, and 1% towards repayment of debt.
days to go:
Expired
investment:
£2,208,212
MysteryVibe creates doctor-recommended sexual health devices. The company combines research and engineering by onboarding leading doctors to design devices that address major sexual health issues such as erectile dysfunction, dryness and pain during intercourse. MysteryVibe has changed over 50,000 lives in 65 countries, witnessed $1 million worth of direct sales in 2020, and became the first sexual health startup to be featured on a BBC documentary. The company has received 20+ international awards including, the coveted Design Week Awards where its product, 'Crescendo', beat the Apple Watch. MysteryVibe has featured in media entities like Men's Health, Women's Health, The Daily Dot, and Forbes, to name a few. The company will use 25% of the investment to expand and scale its digital marketing campaign, 25% to launch two new products, 25% to expand its team, and 25% on building its inventory.
days to go:
Expired
investment:
£498,020
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.
days to go:
Expired
investment:
£522,689
Alyve provides personalised subscription nutrition powered by Artificial Intelligence (AI). It argues that 8.2 million UK vitamin users are looking for personalised nutrition in one capsule. Alyve asserts that its product can fulfil this demand. Users complete a 3-minute questionnaire where their responses are recorded by Alyve's intelligent algorithms. These then, based on the responses, help the user select one of Alyve's nutritional pills best matched to their goals and needs. Alyve then delivers the pills to the user's doorstep every 30 days. The company has recorded 4000+ questionnaires and completed 800+ orders in 25 countries since Q4 of 2020. It aims to become a contender in the $21 billion supplement market. The company will use the investment received to increase marketing efforts, transform Alyve into a household brand, introduce new product lines, increase staff, improve technology, and transform both digital and physical User Experiences (UX).
days to go:
Expired
investment:
£227,782
The Fitfck application (parented by The Social Station Media Group) is a fitness dating app designed to connect like-minded fitness enthusiasts within a socially isolating lifestyle. The app is based on the founders' experience and has been described as 'The UK's fastest-growing fitness social app' by Google, London. The company witnessed 100,000 sign-ups in its first year at a cost per install of £0.30 (Industry average £1.20), has working relationships with Google, Facebook and YouTube, and is available to interested franchisees in 30+ countries. The application has 60,000+ followers across social media handles such as Instagram, Facebook, and Twitter. It has been featured in publications such as Daily Mail, Metro, and London Loves Business. It will use the investment to pay salaries to its staff, increase marketing initiatives, manage server costs, and other expenses.
days to go:
Expired
investment:
Withheld
